Description
Hemagglutinin-1 (HA1) (98-106) is a B cell and T cell binding epitope of hemagglutinin that may be used in the development of an influenza vaccine.
Hemagglutinin-1 (HA1) (98-106) is a B cell and T cell binding epitope of hemagglutinin that may be used in the development of an influenza vaccine.
Cas No. | 92000-76-5 |
---|---|
Purity | ≥95% |
Formula | C53H67N9O17 |
Formula Wt. | 1102.18 |
IUPAC Name | (3S)-3-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-carboxypropanoyl]amino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-4-[[(2S)-1-[[(1S)-1-carboxyethyl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid |
Synonym | HA1 fragment 98-106, HA tag peptide, Influenza Hemagglutinin (HA) Peptide |
Appearance | White to off white powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet | H0100 Info Sheet PDF |
---|
Hatzifoti C, Heath AW. CD40-mediated enhancement of immune responses against three forms of influenza vaccine. Immunology. 2007 Sep;122(1):98-106. PMID: 17472718.